Lateral Flow Assay Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global lateral flow assay test market is experiencing a significant transformation in the healthcare industry, offering a simple yet effective method for detecting various analytes in samples. Also known as lateral flow immunochromatographic assays, these tests have gained widespread acceptance due to their ease of use and cost-effectiveness. Lateral flow assay tests are utilized in clinical diagnostics, including point-of-care (POC) testing, home testing, and laboratory applications, and are even commonly recognized for pregnancy testing.

One of the most notable aspects of lateral flow assay tests is their ability to deliver high-quality results in a short amount of time. These tests have found applications not only in healthcare but also in fields ranging from defense to pharmaceuticals. With ongoing technological advancements, the lateral flow assay test market is rapidly becoming one of the most competitive areas in POC testing devices.

The global lateral flow assay test market is expected to witness positive growth in the coming years, driven by factors such as the increasing prevalence of infectious and communicable diseases and the rising demand for rapid testing in home care settings. Additionally, a growing geriatric population, the expanded use of lateral flow assays in clinical laboratories, the rise in chronic diseases, and ongoing technological upgrades are all expected to contribute to the market's growth. However, challenges such as increased regulations and potential inconsistencies in test results may pose some constraints on market growth.

Geographical Insights:

The lateral flow assay test market is classified into several regions, including North America, Latin America, Europe, Asia-Pacific, the Middle East, and Africa. North America and Europe are expected to remain key markets due to the growing demand for decentralized laboratory testing and the presence of highly advanced healthcare systems. Meanwhile, Asia-Pacific is anticipated to register positive growth driven by government initiatives, improved healthcare infrastructure, and increased demand for quality care at affordable prices.

Key Players:

Some of the key players in the global lateral flow assay test market include:

F. Hoffmann-La Roche AG
Alere Inc.
Danaher Corporation
Abbott Laboratories Inc.
Bio-Rad Laboratories
Johnson & Johnson
Thermo Fisher Scientific Inc.

Market Segmentation:

The global lateral flow assay test market is segmented as follows:

Product Type:

Kits and Reagents
Lateral Flow Assay Readers
Digital/Mobile Readers
Benchtop Readers

Assay Type:

Sandwich Assay Format
Competitive Assay Format
Multiplex Detection Assay Format

Application:

Clinical Diagnostics
Infectious Disease Testing
Cardiac Marker Testing
Pregnancy and Fertility Testing
Cholesterol and Lipid Testing
Drugs-of-abuse Testing
Other Tests
Drug Development and Quality Testing

End User:

Hospitals
Clinics
Home Care
Diagnostic Laboratories
Pharmaceutical and Biotechnology Companies

Regional

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

The global lateral flow assay test market is highly competitive, with major players focusing on the development of innovative technologies to gain a substantial market share. The introduction of newer technologies is expected to encourage patients to shift from traditional laboratory facilities to point-of-care (POC) testing, potentially changing market dynamics in the forecasted period. The consolidation of small laboratory chains into larger entities is leading to a concentration of revenues from small to big players.

In terms of application segments, clinical laboratories are expected to experience significant growth in the global lateral flow assay test market due to the higher prevalence of acute and chronic diseases.

Report Highlights:

Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance

1. Executive Summary

1.1. Global Lateral Flow Assay Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

3.1. Global Lateral Flow Assay Market Production Output, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2023
- 3.1.1. North America
- 3.1.2. Europe
- 3.1.3. Asia Pacific
- 3.1.4. Latin America
- 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Lateral Flow Assay Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Lateral Flow Assay Market Outlook, 2018 - 2031

5.1. Global Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. LFA Readers
    - 5.1.1.1.1. Benchtop Readers
    - 5.1.1.1.2. Handheld Readers
  - 5.1.1.2. LFA Kits
    - 5.1.1.2.1. Test Strips
    - 5.1.1.2.2. Dipsticks
    - 5.1.1.2.3. Cassettes
    - 5.1.1.2.4. Lancets
5.2. Global Lateral Flow Assay Market Outlook, by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Sexually Transmitted Diseases
    - 5.2.1.1.1. Human Deficiency Virus (HIV) Infection
    - 5.2.1.1.2. Gonorrhoea
    - 5.2.1.1.3. Syphilis
    - 5.2.1.1.4. Others
  - 5.2.1.2. Infectious Diseases
    - 5.2.1.2.1. Mosquito-Borne Diseases
    - 5.2.1.2.2. Streptococcus Infections
    - 5.2.1.2.3. Hepatitis Infection
    - 5.2.1.2.4. Gastrointestinal Infections
    - 5.2.1.2.5. Respiratory Tract Infections
    - 5.2.1.2.6. Others
  - 5.2.1.3. Diabetes
  - 5.2.1.4. Pregnancy and Fertility Testing
  - 5.2.1.5. Drug of Abuse Testing
5.3. Global Lateral Flow Assay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Hospital Pharmacies
  - 5.3.1.2. Retail Pharmacies
  - 5.3.1.3. Supermarkets/Hypermarkets
  - 5.3.1.4. e-Commerce
5.4. Global Lateral Flow Assay Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. North America
  - 5.4.1.2. Europe
  - 5.4.1.3. Asia Pacific
  - 5.4.1.4. Latin America
  - 5.4.1.5. Middle East & Africa

6. North America Lateral Flow Assay Market Outlook, 2018 - 2031

6.1. North America Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. LFA Readers
    - 6.1.1.1.1. Benchtop Readers
    - 6.1.1.1.2. Handheld Readers
  - 6.1.1.2. LFA Kits
    - 6.1.1.2.1. Test Strips
    - 6.1.1.2.2. Dipsticks
    - 6.1.1.2.3. Cassettes
    - 6.1.1.2.4. Lancets
6.2. North America Lateral Flow Assay Market Outlook, by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Sexually Transmitted Diseases
    - 6.2.1.1.1. Human Deficiency Virus (HIV) Infection
    - 6.2.1.1.2. Gonorrhoea
    - 6.2.1.1.3. Syphilis
    - 6.2.1.1.4. Others
  - 6.2.1.2. Infectious Diseases
    - 6.2.1.2.1. Mosquito-Borne Diseases
    - 6.2.1.2.2. Streptococcus Infections
    - 6.2.1.2.3. Hepatitis Infection
    - 6.2.1.2.4. Gastrointestinal Infections
    - 6.2.1.2.5. Respiratory Tract Infections
    - 6.2.1.2.6. Others
  - 6.2.1.3. Diabetes
  - 6.2.1.4. Pregnancy and Fertility Testing
  - 6.2.1.5. Drug of Abuse Testing
6.3. North America Lateral Flow Assay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Hospital Pharmacies
  - 6.3.1.2. Retail Pharmacies
  - 6.3.1.3. Supermarkets/Hypermarkets
  - 6.3.1.4. e-Commerce
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. North America Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. U.S. Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.4.1.2. U.S. Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.4.1.3. U.S. Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.4.1.4. Canada Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.4.1.5. Canada Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 6.4.1.6. Canada Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Lateral Flow Assay Market Outlook, 2018 - 2031

7.1. Europe Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. LFA Readers
    - 7.1.1.1.1. Benchtop Readers
    - 7.1.1.1.2. Handheld Readers
  - 7.1.1.2. LFA Kits
    - 7.1.1.2.1. Test Strips
    - 7.1.1.2.2. Dipsticks
    - 7.1.1.2.3. Cassettes
    - 7.1.1.2.4. Lancets
7.2. Europe Lateral Flow Assay Market Outlook, by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Sexually Transmitted Diseases
    - 7.2.1.1.1. Human Deficiency Virus (HIV) Infection
    - 7.2.1.1.2. Gonorrhoea
    - 7.2.1.1.3. Syphilis
    - 7.2.1.1.4. Others
  - 7.2.1.2. Infectious Diseases
    - 7.2.1.2.1. Mosquito-Borne Diseases
    - 7.2.1.2.2. Streptococcus Infections
    - 7.2.1.2.3. Hepatitis Infection
    - 7.2.1.2.4. Gastrointestinal Infections
    - 7.2.1.2.5. Respiratory Tract Infections
    - 7.2.1.2.6. Others
  - 7.2.1.3. Diabetes
  - 7.2.1.4. Pregnancy and Fertility Testing
  - 7.2.1.5. Drug of Abuse Testing
7.3. Europe Lateral Flow Assay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Hospital Pharmacies
  - 7.3.1.2. Retail Pharmacies
  - 7.3.1.3. Supermarkets/Hypermarkets
  - 7.3.1.4. e-Commerce
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Europe Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Germany Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.2. Germany Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.3. Germany Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.4. U.K. Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.5. U.K. Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.6. U.K. Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.7. France Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.8. France Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.9. France Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.10. Italy Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.11. Italy Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.12. Italy Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.13. Turkey Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.14. Turkey Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.15. Turkey Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.16. Russia Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.17. Russia Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.18. Russia Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.19. Rest of Europe Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.20. Rest of Europe Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 7.4.1.21. Rest of Europe Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Lateral Flow Assay Market Outlook, 2018 - 2031

8.1. Asia Pacific Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. LFA Readers
    - 8.1.1.1.1. Benchtop Readers
    - 8.1.1.1.2. Handheld Readers
  - 8.1.1.2. LFA Kits
    - 8.1.1.2.1. Test Strips
    - 8.1.1.2.2. Dipsticks
    - 8.1.1.2.3. Cassettes
    - 8.1.1.2.4. Lancets
8.2. Asia Pacific Lateral Flow Assay Market Outlook, by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Sexually Transmitted Diseases
    - 8.2.1.1.1. Human Deficiency Virus (HIV) Infection
    - 8.2.1.1.2. Gonorrhoea
    - 8.2.1.1.3. Syphilis
    - 8.2.1.1.4. Others
  - 8.2.1.2. Infectious Diseases
    - 8.2.1.2.1. Mosquito-Borne Diseases
    - 8.2.1.2.2. Streptococcus Infections
    - 8.2.1.2.3. Hepatitis Infection
    - 8.2.1.2.4. Gastrointestinal Infections
    - 8.2.1.2.5. Respiratory Tract Infections
    - 8.2.1.2.6. Others
  - 8.2.1.3. Diabetes
  - 8.2.1.4. Pregnancy and Fertility Testing
  - 8.2.1.5. Drug of Abuse Testing
8.3. Asia Pacific Lateral Flow Assay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Hospital Pharmacies
  - 8.3.1.2. Retail Pharmacies
  - 8.3.1.3. Supermarkets/Hypermarkets
  - 8.3.1.4. e-Commerce
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Asia Pacific Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. China Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.2. China Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.3. China Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.4. Japan Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.5. Japan Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.6. Japan Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.7. South Korea Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.8. South Korea Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.9. South Korea Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.10. India Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.11. India Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.12. India Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.13. Southeast Asia Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.14. Southeast Asia Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.15. Southeast Asia Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.16. Rest of Asia Pacific Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.17. Rest of Asia Pacific Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 8.4.1.18. Rest of Asia Pacific Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Lateral Flow Assay Market Outlook, 2018 - 2031

9.1. Latin America Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.1.1. Key Highlights
  - 9.1.1.1. LFA Readers
    - 9.1.1.1.1. Benchtop Readers
    - 9.1.1.1.2. Handheld Readers
  - 9.1.1.2. LFA Kits
    - 9.1.1.2.1. Test Strips
    - 9.1.1.2.2. Dipsticks
    - 9.1.1.2.3. Cassettes
    - 9.1.1.2.4. Lancets
9.2. Latin America Lateral Flow Assay Market Outlook, by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.3. Latin America Lateral Flow Assay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.3.1. Key Highlights
  - 9.3.1.1. Hospital Pharmacies
  - 9.3.1.2. Retail Pharmacies
  - 9.3.1.3. Supermarkets/Hypermarkets
  - 9.3.1.4. e-Commerce
- 9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Latin America Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.4.1. Key Highlights
  - 9.4.1.1. Brazil Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.2. Brazil Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.3. Brazil Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.4. Mexico Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.5. Mexico Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.6. Mexico Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.7. Argentina Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.8. Argentina Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.9. Argentina Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.10. Rest of Latin America Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.11. Rest of Latin America Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 9.4.1.12. Rest of Latin America Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Lateral Flow Assay Market Outlook, 2018 - 2031

10.1. Middle East & Africa Lateral Flow Assay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.1.1. Key Highlights
  - 10.1.1.1. LFA Readers
    - 10.1.1.1.1. Benchtop Readers
    - 10.1.1.1.2. Handheld Readers
  - 10.1.1.2. LFA Kits
    - 10.1.1.2.1. Test Strips
    - 10.1.1.2.2. Dipsticks
    - 10.1.1.2.3. Cassettes
    - 10.1.1.2.4. Lancets
10.2. Middle East & Africa Lateral Flow Assay Market Outlook, by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.2.1. Key Highlights
  - 10.2.1.1. Sexually Transmitted Diseases
    - 10.2.1.1.1. Human Deficiency Virus (HIV) Infection
    - 10.2.1.1.2. Gonorrhoea
    - 10.2.1.1.3. Syphilis
    - 10.2.1.1.4. Others
  - 10.2.1.2. Infectious Diseases
    - 10.2.1.2.1. Mosquito-Borne Diseases
    - 10.2.1.2.2. Streptococcus Infections
    - 10.2.1.2.3. Hepatitis Infection
    - 10.2.1.2.4. Gastrointestinal Infections
    - 10.2.1.2.5. Respiratory Tract Infections
    - 10.2.1.2.6. Others
  - 10.2.1.3. Diabetes
  - 10.2.1.4. Pregnancy and Fertility Testing
  - 10.2.1.5. Drug of Abuse Testing
10.3. Middle East & Africa Lateral Flow Assay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.3.1. Key Highlights
  - 10.3.1.1. Hospital Pharmacies
  - 10.3.1.2. Retail Pharmacies
  - 10.3.1.3. Supermarkets/Hypermarkets
  - 10.3.1.4. e-Commerce
- 10.3.2. BPS Analysis/Market Attractiveness Analysis
10.4. Middle East & Africa Lateral Flow Assay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.4.1. Key Highlights
  - 10.4.1.1. GCC Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.2. GCC Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.3. GCC Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.4. South Africa Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.5. South Africa Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.6. South Africa Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.7. Egypt Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.8. Egypt Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.9. Egypt Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.10. Nigeria Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.11. Nigeria Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.12. Nigeria Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.13. Rest of Middle East & Africa Lateral Flow Assay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.14. Rest of Middle East & Africa Lateral Flow Assay Market by Clinical Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
  - 10.4.1.15. Rest of Middle East & Africa Lateral Flow Assay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
- 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

11.1. By End User vs by Clinical Application Heat map
11.2. Manufacturer vs by Clinical Application Heatmap
11.3. Company Market Share Analysis, 2023
11.4. Competitive Dashboard
11.5. Company Profiles
- 11.5.1. ThermoFisher Scientific Inc.
  - 11.5.1.1. Company Overview
  - 11.5.1.2. Product Portfolio
  - 11.5.1.3. Financial Overview
  - 11.5.1.4. Business Strategies and Development
- 11.5.2. F. Hoffmann-La Roche
  - 11.5.2.1. Company Overview
  - 11.5.2.2. Product Portfolio
  - 11.5.2.3. Financial Overview
  - 11.5.2.4. Business Strategies and Development
- 11.5.3. Abbott Laboratories
  - 11.5.3.1. Company Overview
  - 11.5.3.2. Product Portfolio
  - 11.5.3.3. Financial Overview
  - 11.5.3.4. Business Strategies and Development
- 11.5.4. Becton, Dickinson & Company
  - 11.5.4.1. Company Overview
  - 11.5.4.2. Product Portfolio
  - 11.5.4.3. Financial Overview
  - 11.5.4.4. Business Strategies and Development
- 11.5.5. PerkinElmer Inc.
  - 11.5.5.1. Company Overview
  - 11.5.5.2. Product Portfolio
  - 11.5.5.3. Financial Overview
  - 11.5.5.4. Business Strategies and Development
- 11.5.6. Siemens Healthineers
  - 11.5.6.1. Company Overview
  - 11.5.6.2. Product Portfolio
  - 11.5.6.3. Financial Overview
  - 11.5.6.4. Business Strategies and Development
- 11.5.7. QIAGEN N.V.
  - 11.5.7.1. Company Overview
  - 11.5.7.2. Product Portfolio
  - 11.5.7.3. Financial Overview
  - 11.5.7.4. Business Strategies and Development
- 11.5.8. bioMerieux SA
  - 11.5.8.1. Company Overview
  - 11.5.8.2. Product Portfolio
  - 11.5.8.3. Financial Overview
  - 11.5.8.4. Business Strategies and Development
- 11.5.9. Bio-Rad Laboratories, Inc.
  - 11.5.9.1. Company Overview
  - 11.5.9.2. Product Portfolio
  - 11.5.9.3. Financial Overview
  - 11.5.9.4. Business Strategies and Development
- 11.5.10. Maternova Inc.
  - 11.5.10.1. Company Overview
  - 11.5.10.2. Product Portfolio
  - 11.5.10.3. Financial Overview
  - 11.5.10.4. Business Strategies and Development
- 11.5.11. Quidel Corporation
  - 11.5.11.1. Company Overview
  - 11.5.11.2. Product Portfolio
  - 11.5.11.3. Financial Overview
  - 11.5.11.4. Business Strategies and Development
- 11.5.12. Healgen Scientific, LLC.
  - 11.5.12.1. Company Overview
  - 11.5.12.2. Product Portfolio
  - 11.5.12.3. Financial Overview
  - 11.5.12.4. Business Strategies and Development
- 11.5.13. Meridian Bioscience Inc.
  - 11.5.13.1. Company Overview
  - 11.5.13.2. Product Portfolio
  - 11.5.13.3. Financial Overview
  - 11.5.13.4. Business Strategies and Development
- 11.5.14. Abcam plc.
  - 11.5.14.1. Company Overview
  - 11.5.14.2. Product Portfolio
  - 11.5.14.3. Financial Overview
  - 11.5.14.4. Business Strategies and Development

12. Appendix

12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations